Taiflex Scientific Co., Ltd. (TPE:8039)
Taiwan · Delayed Price · Currency is TWD 144.00
-5.50 (-3.68%)
May 15, 2026, 1:30 PM CST
Taiflex Scientific Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 623.95 | 535.12 | 592.78 | 422.97 | 700.48 | 734.65 |
Depreciation & Amortization | 539.39 | 526.9 | 508.93 | 437.18 | 410.4 | 375.11 |
Other Amortization | 19.45 | 19.45 | 20.65 | 22.03 | 21.5 | 21.82 |
Loss (Gain) From Sale of Assets | -0.36 | -0.76 | 33.45 | 0.31 | -0.43 | 6.69 |
Asset Writedown & Restructuring Costs | -1.02 | -1.02 | 26.23 | - | - | -2.88 |
Loss (Gain) From Sale of Investments | -64.23 | -49.62 | 26.88 | -6.15 | 31.48 | 10.83 |
Loss (Gain) on Equity Investments | 2.23 | 3.54 | 2.11 | 11.16 | 1.6 | 7.97 |
Stock-Based Compensation | 3.27 | 2.3 | 8.09 | 11.03 | - | - |
Provision & Write-off of Bad Debts | 9.85 | 26.67 | 28.43 | 2.96 | 6.07 | -4.39 |
Other Operating Activities | 189.12 | 143.96 | 59.58 | 6.88 | 276.86 | -54.59 |
Change in Accounts Receivable | -163.89 | -570.91 | -90.74 | -107.48 | 36.25 | 424.71 |
Change in Inventory | -134.06 | -267.35 | -285.2 | 291.76 | -28.15 | -636.6 |
Change in Accounts Payable | -3.24 | 133.61 | 289.77 | 290.06 | -526.93 | -468.58 |
Change in Unearned Revenue | 6.41 | 6.5 | -0.32 | 0.72 | -1.1 | -0.66 |
Change in Other Net Operating Assets | 216.57 | 154.14 | 231.88 | -91.56 | 274.3 | -170.44 |
Operating Cash Flow | 1,274 | 707.47 | 1,421 | 1,272 | 1,142 | 228.23 |
Operating Cash Flow Growth | 115.10% | -50.21% | 11.71% | 11.40% | 400.24% | -79.86% |
Capital Expenditures | -622.04 | -594.8 | -693.2 | -1,015 | -977.07 | -529.36 |
Sale of Property, Plant & Equipment | 3.58 | 3.6 | 15.59 | 0.09 | 1.15 | 2.9 |
Cash Acquisitions | 14.75 | 14.75 | - | - | - | - |
Divestitures | 48.88 | 48.88 | 6.98 | - | - | - |
Sale (Purchase) of Intangibles | -1.28 | -1.25 | -8.06 | -1.21 | -4.36 | -12.1 |
Investment in Securities | 128.53 | 318.55 | 254.76 | 33.13 | 291.28 | -545.21 |
Other Investing Activities | 60.74 | 0.56 | -1.99 | -1.53 | 0.7 | 11.67 |
Investing Cash Flow | -366.85 | -209.72 | -425.92 | -984.67 | -688.3 | -1,072 |
Short-Term Debt Issued | - | 82.97 | 124.92 | - | - | 640 |
Long-Term Debt Issued | - | - | - | 7.51 | - | 2,191 |
Total Debt Issued | 414.83 | 82.97 | 124.92 | 7.51 | - | 2,831 |
Short-Term Debt Repaid | - | - | - | -36.14 | -535 | - |
Long-Term Debt Repaid | - | -47.11 | -66.75 | -32.38 | -458.78 | -22.46 |
Total Debt Repaid | -48.56 | -47.11 | -66.75 | -68.52 | -993.78 | -22.46 |
Net Debt Issued (Repaid) | 366.27 | 35.86 | 58.18 | -61.02 | -993.78 | 2,809 |
Issuance of Common Stock | 39.82 | 27.55 | - | - | - | - |
Common Dividends Paid | -640.69 | -640.69 | -209.12 | -522.8 | -522.8 | -522.8 |
Other Financing Activities | 59.58 | 58.68 | -14.26 | 15.74 | 4.44 | 19.75 |
Financing Cash Flow | -175.01 | -518.61 | -165.2 | -568.07 | -1,512 | 2,306 |
Foreign Exchange Rate Adjustments | 17.6 | 9.66 | 94.25 | -18.08 | 52.71 | 15.13 |
Net Cash Flow | 750.19 | -11.2 | 923.93 | -298.97 | -1,006 | 1,477 |
Free Cash Flow | 652.41 | 112.67 | 727.6 | 256.7 | 164.64 | -301.13 |
Free Cash Flow Growth | - | -84.52% | 183.45% | 55.92% | - | - |
Free Cash Flow Margin | 6.04% | 1.06% | 7.32% | 3.15% | 1.89% | -3.20% |
Free Cash Flow Per Share | 2.48 | 0.43 | 2.81 | 0.98 | 0.63 | -1.17 |
Cash Interest Paid | 16.22 | 16.22 | 15.94 | 10.2 | 11.47 | 13.93 |
Cash Income Tax Paid | 31.18 | 31.18 | 134.7 | 146.61 | 49 | 318.6 |
Levered Free Cash Flow | 253 | -213.73 | 463.43 | 161.83 | -129.12 | -405.23 |
Unlevered Free Cash Flow | 267.36 | -199.62 | 483.02 | 182.11 | -107.12 | -392.23 |
Change in Working Capital | -47.2 | -499.07 | 113.68 | 363.48 | -306.27 | -866.97 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.